American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.

  • Take Action to Protect Medical and Public Health Research

    In July, the Senate Appropriations Committee approved a draft spending bill that would provide nearly $31 billion for the National Institutes of Health (NIH) in fiscal year (FY) 2014, an amount that would replace funding lost due to sequestration and provide a small increase over the FY 2012 NIH budget.

  • Urge Congress to Pass the SGR Repeal and Medicare Provider Payment Modernization Act and Provide Stable Medicare Physician Payments

    On February 6, 2014 the leadership of the House Ways and Means and Energy and Commerce Committees and the Senate Finance Committee released a bi-partisan and bicameral bill to repeal the Sustainable Growth Rate (SGR) formula that has driven annual reductions in Medicare payment for physician services. Your advocacy is needed to ensure that the legislation can be considered by the full House of Representatives and Senate before the short-term physician fee update expires on April 1, 2014.

View all action alerts
  • ASH Comments on Proposals Covering Medicare Payments to Physicians and Hospitals in 2015

    ASH submitted comment letters covering Medicare proposals for payments and associated policies for services paid under the physician fee schedule and the hospital outpatient prospective payment system.

  • ASH to Co-Host Congressional Briefing on Sickle Cell Disease

    ASH and the Sickle Cell Disease Association of America, in cooperation with the Sickle Cell Disease Congressional Caucus, will host a Congressional briefing September 16, 2014, on sickle cell disease (SCD) highlighting the need for state-of-the-art clinical care for SCD patients.

  • ASH and ASCO Co-Host Annual CAC Meeting

    On Friday July 25, 2014, ASH and the American Society of Clinical Oncology (ASCO) co-hosted the annual Hematology and Oncology Carrier Advisory Committee (CAC) network meeting. The meeting is intended to provide attendees with a better understanding of the CAC process; discuss issues of common concern and develop solutions; and improve the overall CAC process throughout the year.

  • CMS Announces Decision to Amend Policy that Had Required Prior Authorization for All Part D Drugs

    In June, ASH joined an effort to advocate that Medicare change recent rules that required Medicare patients who had entered hospice status to go through prior authorization for all prescription drugs.  ASH and the other organizations that worked on this issue felt that this requirement was a significant hurdle to be faced by patients whose disease had necessitated hospice status.

View all policy news
back to top